• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组织化学标志物的监督聚类以区分非典型和非非典型子宫内膜增生。

Supervised clustering of immunohistochemical markers to distinguish atypical and non-atypical endometrial hyperplasia.

作者信息

Laas Enora, Ballester Marcos, Cortez Annie, Gonin Julie, Canlorbe Geoffroy, Daraï Emile, Graesslin Olivier

机构信息

Service de Gynécologie-Obstétrique, Hôpital Tenon , AP-HP, Paris , France .

出版信息

Gynecol Endocrinol. 2015 Apr;31(4):282-5. doi: 10.3109/09513590.2014.989981. Epub 2014 Dec 12.

DOI:10.3109/09513590.2014.989981
PMID:25495249
Abstract

The risk of endometrial hyperplasia (EH) progressing into endometrioid endometrial cancer ranges from 1% for simple EH without atypia (EHWA) to 46.2% for atypical EH (AEH). Differentiation between both entities is crucial to determine optimal management. As preoperative diagnosis of AEH can be difficult, we aimed to establish clusters of immunohistochemical markers to distinguish EHWA from AEH. We studied 13 immunohistochemical markers (steroid receptors, pro/anti-apoptotic proteins, metalloproteinases (MMP), tissue inhibitor of metalloproteinase (TIMP), CD44 isoforms) known for their role in endometrial pathology. Using supervised clustering, we determined clusters of co-expressed proteins which contributed the most in differentiating EHWA from AEH. From 39 tissue samples (17 EHWA and 22 AEH), we found three clusters of co-expressed proteins: Cluster 1 included two proteins (over-expression of estrogen receptor (ER) and under-expression of progesterone receptor (PR) B in AEH compared to EHWA); Cluster 2: an ER, PR A, MMP-2 and TIMP-1 over-expression and a PR B and TIMP-2 under-expression; Cluster 3: over-expression of ER and MMP-7 and under-expression of PR B and TIMP-2. AEH can be accurately distinguished from EHWA using a supervised clustering of immunohistochemical markers. This promising approach could be useful to improve the preoperative diagnosis of EH.

摘要

子宫内膜增生(EH)进展为子宫内膜样癌的风险范围从无不典型性的单纯EH(EHWA)的1%到不典型EH(AEH)的46.2%。区分这两种情况对于确定最佳治疗方案至关重要。由于术前诊断AEH可能困难,我们旨在建立免疫组化标志物簇以区分EHWA与AEH。我们研究了13种已知在子宫内膜病理中起作用的免疫组化标志物(类固醇受体、促/抗凋亡蛋白、金属蛋白酶(MMP)、金属蛋白酶组织抑制剂(TIMP)、CD44异构体)。使用监督聚类,我们确定了在区分EHWA与AEH中贡献最大的共表达蛋白簇。从39个组织样本(17个EHWA和22个AEH)中,我们发现了三个共表达蛋白簇:簇1包括两种蛋白(与EHWA相比,AEH中雌激素受体(ER)过表达和孕激素受体(PR)B低表达);簇2:ER、PR A、MMP-2和TIMP-1过表达以及PR B和TIMP-2低表达;簇3:ER和MMP-7过表达以及PR B和TIMP-2低表达。使用免疫组化标志物的监督聚类可以准确区分AEH与EHWA。这种有前景的方法可能有助于改善EH的术前诊断。

相似文献

1
Supervised clustering of immunohistochemical markers to distinguish atypical and non-atypical endometrial hyperplasia.免疫组织化学标志物的监督聚类以区分非典型和非非典型子宫内膜增生。
Gynecol Endocrinol. 2015 Apr;31(4):282-5. doi: 10.3109/09513590.2014.989981. Epub 2014 Dec 12.
2
Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.免疫组织化学标志物的监督聚类,以区分非典型子宫内膜增生与 1 级子宫内膜癌。
Gynecol Oncol. 2014 May;133(2):205-10. doi: 10.1016/j.ygyno.2014.02.018. Epub 2014 Feb 17.
3
Analysis of PTEN, estrogen receptor α and progesterone receptor expression in endometrial hyperplasia using tissue microarray.利用组织芯片分析子宫内膜增生中PTEN、雌激素受体α和孕激素受体的表达
Pol J Pathol. 2011 Sep;62(3):133-8.
4
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.基质金属蛋白酶-7[校正为基质金属蛋白酶-2]、-11及金属蛋白酶组织抑制剂-1在正常、增生及肿瘤性子宫内膜中表达的意义
Anticancer Res. 2007 Jan-Feb;27(1A):95-105.
5
Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.MT1 - 基质金属蛋白酶、基质金属蛋白酶组织抑制因子 - 1、基质金属蛋白酶组织抑制因子 - 2和基质金属蛋白酶组织抑制因子 - 3信使核糖核酸在正常、增生性和肿瘤性子宫内膜中的定位。子宫内膜腺癌中这些因子表达增强与低分化相关。
Am J Clin Pathol. 2000 Sep;114(3):402-11. doi: 10.1093/ajcp/114.3.402.
6
Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.金属蛋白酶-2、-7和-9以及金属蛋白酶组织抑制剂-1和-2在正常、增生性和肿瘤性子宫内膜中的表达:一项临床病理相关性研究。
Ann Oncol. 2006 Apr;17(4):637-45. doi: 10.1093/annonc/mdj129. Epub 2006 Jan 11.
7
Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.心脏和神经嵴衍生表达转录本2(HAND2):一种用于识别非典型增生和I型子宫内膜癌的新型生物标志物。
Int J Gynecol Pathol. 2015 Jan;34(1):65-73. doi: 10.1097/PGP.0000000000000106.
8
Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia.子宫内膜增生相关炎症:在子宫内膜增生的发生和发展中的作用。
Inflamm Res. 2016 Oct;65(10):785-94. doi: 10.1007/s00011-016-0960-z. Epub 2016 Jun 16.
9
Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature.经子宫内膜活检诊断的非典型子宫内膜增生的临床结局:机构经验和文献复习。
Am J Surg Pathol. 2012 Nov;36(11):1683-90. doi: 10.1097/PAS.0b013e31825dd4ff.
10
Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.是否应该评估孕激素和雌激素受体以预测子宫内膜增生和癌症保守治疗的反应?系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2019 Aug;98(8):976-987. doi: 10.1111/aogs.13586. Epub 2019 Mar 28.

引用本文的文献

1
ER and COX2 expression in endometrial hyperplasia processes.子宫内膜增生过程中的 ER 和 COX2 表达。
Medicine (Baltimore). 2023 Aug 18;102(33):e34864. doi: 10.1097/MD.0000000000034864.
2
Expression of CD117, CD34, and VEGF proteins in progression from endometrial hyperplasia to endometrioid carcinoma.CD117、CD34和VEGF蛋白在子宫内膜增生向子宫内膜样癌进展过程中的表达
Int J Clin Exp Pathol. 2020 Aug 1;13(8):2115-2122. eCollection 2020.
3
F-FDG PET/CT Quantitative Parameters and Texture Analysis Effectively Differentiate Endometrial Precancerous Lesion and Early-Stage Carcinoma.
F-FDG PET/CT定量参数及纹理分析可有效鉴别子宫内膜癌前病变与早期癌。
Mol Imaging. 2019 Jan-Dec;18:1536012119856965. doi: 10.1177/1536012119856965.
4
Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer.脂肪因子和激素受体的监督聚类预测1型子宫内膜癌肥胖女性群体的预后。
Int J Mol Sci. 2017 May 13;18(5):1055. doi: 10.3390/ijms18051055.